Evestra, Inc.
PrivateLast Round
Grant
Sep 6, 2022
Total Funding Raised
$23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evestra, Inc. operates in Healthcare & Life Sciences and is based in Schertz, Texas. Its latest recorded funding round was a Grant round in September 2022.
Evestra, Inc. is a biopharmaceutical company that develops innovative products in women's healthcare and oncology using steroid medicinal chemistry and vaginal drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evestra, Inc. Comparables
Compare Evestra, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VaRi Bioscience GmbH | 81% | |
| AnelleO | 78% | |
| Daré Bioscience Inc | 76% |
For institutional investors. Book with your work email.
Evestra, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 6, 2022 | ||||
| Grant | Mar 30, 2022 | ||||
| Grant | Nov 1, 2020 | ||||
| Strategic | Jul 22, 2019 | ||||
| Grant | Jan 24, 2017 | ||||
Seed | May 12, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evestra, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| Gates Foundation | Grant |
| European Regional Development Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 187% MoM, reaching 2.5K.
- Nov 10, 2025
Monthly visitors increased 53% MoM.
For institutional investors. Book with your work email.
Evestra, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evestra, Inc.'s valuation, stock price, and market status.
Is Evestra, Inc. a public or private company?
Evestra, Inc. is a private company.
What is the current stock price of Evestra, Inc.?
Evestra, Inc. is a private company, so its shares have no public market price. Caplight tracks Evestra, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evestra, Inc. worth (valuation)?
Valuation information for Evestra, Inc. is not publicly available.
Can I buy Evestra, Inc. stock?
Evestra, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evestra, Inc.'s last funding round?
Evestra, Inc.'s most recent funding round was Grant on September 6, 2022.
Who are the main investors in Evestra, Inc.?
Key investors in Evestra, Inc. include United States Department of Defense, NIH RADx, Gates Foundation, European Regional Development Fund.
Will Evestra, Inc. IPO soon?
No public IPO plans have been announced for Evestra, Inc..
How can I track Evestra, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Evestra, Inc.'s shares on secondary markets.